Skip to main content
SpringerLink
Log in

Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Recial disparity in the presentation of breast cancer and the outcome of its treatment is well established. However, the causes remain unexplained. The scarcity of reports about the prognostic significance of p53, bcl-2, and HER-2/neu in Arab females with breast cancer has been the impetus to this study. We evaluated the prognostic significance of altered expression of p53, bcl-2,HER-2/neu in Omani Arab females with non-metastatic breast cancer with correlation to other established prognostic factors. We have retrospectively analyzed the immunohistochemical expression of p53, HER-2/neu and bcl-2 in paraffin embedded blocks of 72 females diagnosed with invasive breast cancer between 1992 and 2002. The expression of the above proteins was correlated with other prognostic factors and univariate and multivariate analysis was carried out for all prognostic factors. Overexpression of p53 significantly correlated with younger age (<40), pre-menopausal status, poor differentiation with inverse correlation with bcl-2 expression. Expression of bcl-2 immunopostivity significantly correlated to low histological grade and positive estrogen and progesterone receptor status. On univariate and multivariate p53 overexpression and lack of bcl-2 immunostaining resulted in worse survival outcome, but notHer-2/neu overexpression. Expression patterns of p53 and bcl-2 are independent predictors of survival in Omani Arab population which may help to stratify these patients into different risk groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rose DP, Royak-Schaler R: Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev 25:16–31, 2001

    PubMed  CAS  Google Scholar 

  2. Ikpatt OF, Kuopio T, Collan Y: Proliferation in African breast cancer: biology and prognostication in Nigerian breast cancer material. Mod Pathol15:78, 2002

    Article  Google Scholar 

  3. Simon MS SR: Racial differences in breast cancer survival: the interaction of socio-economic status and tumor biology. Am J Obstet Gynecol 176:233–236, 1997

    Article  Google Scholar 

  4. Cheng SH, Tsou MH, Liu MC, et al: Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 63:213–23, 2000

    Article  PubMed  CAS  Google Scholar 

  5. Chow LW TA, Cheung KL, Au GK, et al: Current status of breast cancer in Hong Kong. Chin Med J (Engl) 110:474–8, 1997

    CAS  Google Scholar 

  6. Ezzat A RM, Zwaan F, Brigden M, et al: The lack of age as a significant prognostic factor in non-metastatic breast cancer. Eur J Surg Oncol 24:23–7, 1998

    Article  PubMed  CAS  Google Scholar 

  7. Fakhro AE FB, Al-Asheeri N, Al-Ekri SA: Breast cancer: patient characteristics and survival analysis at Salmaniya Medical Complex, Bahrain. Eastern Mediterranean Health Journal 5:430–439, 1999

    PubMed  CAS  Google Scholar 

  8. Maalej M FH, Ben Salem S, Daoud J, et al: Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer 86:302–6., 1999

    PubMed  CAS  Google Scholar 

  9. Malik IA: Clinico-pathological features of breast cancer in Pakistan. J Pak Med Assoc 52:100–4, 2002

    PubMed  CAS  Google Scholar 

  10. Slamon DJ, DeKernion JB, Verma IM, et al: Expression of cellular oncogenes in human malignancies. Science 224:256–62, 1984

    Article  PubMed  CAS  Google Scholar 

  11. Bankfalvi A, Tory K, Kemper M, et al: Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma. Pathol Res Pract 196:489–501, 2000

    PubMed  CAS  Google Scholar 

  12. BarbareschiM, Caffo O, Veronese S, et al: Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol 27:1149–55, 1996

    Article  Google Scholar 

  13. Ferrero-Pous M, Hacene K, Bouchet C, et al: Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis. Clin Cancer Res 6:4745–54, 2000

    PubMed  CAS  Google Scholar 

  14. Jansen RL, Joosten-Achjanie SR, Volovics A, et al: Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer. Anticancer Res 18:4455–62, 1998

    PubMed  CAS  Google Scholar 

  15. Le MG, Mathieu MC, Douc-Rasy S, et al: c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Int J Cancer 84:562–7, 1999

    Article  PubMed  CAS  Google Scholar 

  16. Nunes RA, Harris LN: The HER2 extracellular domain as a prognostic and predictive factor in breast cancer. Clin Breast Cancer 3:125–35, 2002

    PubMed  Google Scholar 

  17. Ross JS, Fletcher JA: TheHER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 16:413–28, 1998

    Article  PubMed  CAS  Google Scholar 

  18. Sahin AA: Biologic and clinical significance ofHER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol 7:158–66, 2000

    PubMed  CAS  Google Scholar 

  19. Silvestrini R, Veneroni S, Daidone MG, et al: The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499–504, 1994

    Article  PubMed  CAS  Google Scholar 

  20. Sjogren S, Inganas M, Lindgren A, et al: Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol 16:462–9, 1998

    PubMed  CAS  Google Scholar 

  21. Zhang GJ, Tsuda H, Adachi I, et al: Prognostic indicators for breast cancer patients with one to three regional lymph node métastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins. Jpn J Clin Oncol 27:371–7, 1997

    Article  PubMed  CAS  Google Scholar 

  22. El-Ahmady O, El-Salahy E, Mahmoud M, et al: Multivariate analysis of bcl-2, apoptosis, p53 andHER-2/neu in breast cancer: a short-term follow-up. Anticancer Res 22:2493–9, 2002

    PubMed  CAS  Google Scholar 

  23. Temmim L, Baker H, Sinowatz F: Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women. Anticancer Res 21:743–8, 2001

    PubMed  CAS  Google Scholar 

  24. Doglioni C, Dei Tos AP, Laurino L, et al: The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 424:47–51, 1994

    Article  PubMed  CAS  Google Scholar 

  25. Al-Lawati JA, Santhosh-Kumar CR, Mohammed AJ, et al: Cancer incidence in Oman, 1993–1997. East Mediterr Health J 5:1035–41, 1999

    PubMed  CAS  Google Scholar 

  26. Rosanelli GP, Steindorf Er P, Wirnsberger GH, et al: Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Anticancer Res 15:581–6, 1995

    PubMed  CAS  Google Scholar 

  27. Fresno M, Molina R, Perez del Rio MJ, et al: p53 expression is of independent predictive value in lymph node-negative breast carcinoma. Eur J Cancer 33:1268–74, 1997

    Article  PubMed  CAS  Google Scholar 

  28. Bosari S, Lee AK, Viale G, et al: Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with longterm follow-up. Virchows Arch A Pathol Anat Histopathol 421:291–5, 1992

    Article  PubMed  CAS  Google Scholar 

  29. Quinn CM, Ostrowski JL, Harkins L, et al: Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins. Histopathology 33:531–6, 1998

    Article  PubMed  CAS  Google Scholar 

  30. Hellemans P, van Dam PA, Weyler J, et al: Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72:354–60, 1995

    PubMed  CAS  Google Scholar 

  31. Ioachim EE, Malamou-Mitsi V, Kamina SA, et al: Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Anticancer Res 20:4221–5, 2000

    PubMed  CAS  Google Scholar 

  32. Haldar S, Negrini M, Monne M, et al: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095–7, 1994

    PubMed  CAS  Google Scholar 

  33. Vairo G, Innes KM, Adams JM: Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13:1511–9, 1996

    PubMed  CAS  Google Scholar 

  34. Miyashita T, Kitada S, Krajewski S, Home WA, Delia D, Reed JC: Overexpression of the Bcl-2 protein increases the half-life of p21 Bax J Biol Chem 270:26049–26052, 1995

    Article  PubMed  CAS  Google Scholar 

  35. Thor AD, Berry DA, Budman DR, et al: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst 90:1346–60, 1998

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Unit Department of Medicine, Sultan Qaboos University, Oman

    Mansour A-Moundhri, I. Burney & A. Rizvi

  2. Department of Pathology, Sultan Qaboos University, Oman

    V. Nirmala & K. Al-Mawaly

  3. Department of Epidemiology and Medical Statistics, Sultan Qaboos University, Oman

    S. Ganguly

  4. Department of Surgery College of Medicine, Sultan Qaboos University, Oman

    C. Grant

Authors
  1. Mansour A-Moundhri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Nirmala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Al-Mawaly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Ganguly
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Burney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Rizvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

A-Moundhri, M., Nirmala, V., Al-Mawaly, K. et al. Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer. Pathol. Oncol. Res. 9, 226–231 (2003). https://doi.org/10.1007/BF02893382

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893382

Keywords

Search

Navigation